FR2902010B1 - Utilisation de la 1,7 dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene destine au traitement d'un trouble neuropsychiatrique - Google Patents
Utilisation de la 1,7 dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene destine au traitement d'un trouble neuropsychiatriqueInfo
- Publication number
- FR2902010B1 FR2902010B1 FR0605189A FR0605189A FR2902010B1 FR 2902010 B1 FR2902010 B1 FR 2902010B1 FR 0605189 A FR0605189 A FR 0605189A FR 0605189 A FR0605189 A FR 0605189A FR 2902010 B1 FR2902010 B1 FR 2902010B1
- Authority
- FR
- France
- Prior art keywords
- psychoanaleptic
- anxiogenic
- dimethylxanthine
- medicament
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0605189A FR2902010B1 (fr) | 2006-06-12 | 2006-06-12 | Utilisation de la 1,7 dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene destine au traitement d'un trouble neuropsychiatrique |
TW096120502A TW200815013A (en) | 2006-06-12 | 2007-06-07 | Use of 1,7-dimethylxanthine for the manufacture of a non-anxiogenic psychoanaleptic drug for the treatment of a neuropsychiatric disorder |
CA002654891A CA2654891A1 (fr) | 2006-06-12 | 2007-06-08 | Utilisation de 1,7-dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene pour le traitement d'un trouble neuropsychiatrique |
US12/304,377 US20090325984A1 (en) | 2006-06-12 | 2007-06-08 | Use of 1,7-dimethylxanthine for the manufacture of a non-anxiogenic psychoanaleptic drug for the treatment of a neuropsychiatric disorder |
EP07730023A EP2026812A1 (fr) | 2006-06-12 | 2007-06-08 | Utilisation de 1,7-diméthylxanthine pour la fabrication d'un médicament psychoanaleptique non anxiogène pour le traitement d'un trouble neuropsychiatrique |
PCT/EP2007/055668 WO2007144315A1 (fr) | 2006-06-12 | 2007-06-08 | Utilisation de 1,7-diméthylxanthine pour la fabrication d'un médicament psychoanaleptique non anxiogène pour le traitement d'un trouble neuropsychiatrique |
JP2009514766A JP2009539921A (ja) | 2006-06-12 | 2007-06-08 | 神経精神障害の治療用の非不安誘発性精神賦活薬の製造のための1,7−ジメチルキサンチンの使用 |
ARP070102566A AR061446A1 (es) | 2006-06-12 | 2007-06-12 | Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0605189A FR2902010B1 (fr) | 2006-06-12 | 2006-06-12 | Utilisation de la 1,7 dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene destine au traitement d'un trouble neuropsychiatrique |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2902010A1 FR2902010A1 (fr) | 2007-12-14 |
FR2902010B1 true FR2902010B1 (fr) | 2008-08-22 |
Family
ID=37592447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0605189A Expired - Fee Related FR2902010B1 (fr) | 2006-06-12 | 2006-06-12 | Utilisation de la 1,7 dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene destine au traitement d'un trouble neuropsychiatrique |
Country Status (8)
Country | Link |
---|---|
US (1) | US20090325984A1 (fr) |
EP (1) | EP2026812A1 (fr) |
JP (1) | JP2009539921A (fr) |
AR (1) | AR061446A1 (fr) |
CA (1) | CA2654891A1 (fr) |
FR (1) | FR2902010B1 (fr) |
TW (1) | TW200815013A (fr) |
WO (1) | WO2007144315A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150100699A (ko) * | 2012-10-24 | 2015-09-02 | 주식회사 한국피부임상과학연구소 | 카페인과 파라잔틴에 의한 지방 분해 슬리밍 조성물 |
US11950616B2 (en) | 2019-06-21 | 2024-04-09 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
WO2021151094A1 (fr) * | 2020-01-23 | 2021-07-29 | Ingenious Ingredients, LP | Composition bioactive à base de paraxanthine et son procédé d'utilisation |
TW202227085A (zh) * | 2020-09-14 | 2022-07-16 | 美商萊罕製藥股份有限公司 | 氘代副黃嘌呤(paraxanthine)及其用途 |
WO2022204598A1 (fr) * | 2021-03-26 | 2022-09-29 | Ingenious Ingredients, LP | Utilisation de paraxanthine pour réduire la fatigue mentale induite par l'exercice |
JP2024513831A (ja) * | 2021-03-31 | 2024-03-27 | ピーエックス・アイエヌジー,エルエルシー | ビデオゲーマーのパフォーマンスを改善するためのパラキサンチンの使用 |
EP4329632A1 (fr) | 2021-04-29 | 2024-03-06 | Rarebird, Inc. | Compositions et leurs procédés de production |
US20230037138A1 (en) * | 2021-07-27 | 2023-02-02 | Ingenious Ingredients, LP | Paraxanthine-based caffeine substitute compositions and method of use thereof in slow caffeine metabolizers |
CA3234492A1 (fr) * | 2021-10-12 | 2023-04-20 | Ralf Jager | Compositions de dileucine et leurs procedes d'utilisation pour la perte de graisse |
US20230165868A1 (en) * | 2021-11-28 | 2023-06-01 | Ingenious Ingredients, LP | Paraxanthine-based compositions for enhancing muscle function, nitric oxide signaling, and/or muscle glycogen levels |
US11969430B1 (en) * | 2023-03-10 | 2024-04-30 | Axcess Global Sciences, Llc | Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001080893A1 (fr) * | 2000-04-26 | 2001-11-01 | Eisai Co., Ltd. | Compositions medicinales favorisant les mouvements intestinaux |
DE602004021574D1 (de) * | 2003-02-26 | 2009-07-30 | Univ Johns Hopkins | Modulatorische verbindungen und verfahren für glutamattransport |
EP1998766A2 (fr) * | 2005-12-16 | 2008-12-10 | Ironwood Pharmaceuticals, Inc. | Composes indole utiles |
JP2009528059A (ja) * | 2006-02-28 | 2009-08-06 | メタボロン インコーポレイテッド | 筋萎縮性側索硬化症に関するバイオマーカー及びそれらを使用する方法 |
-
2006
- 2006-06-12 FR FR0605189A patent/FR2902010B1/fr not_active Expired - Fee Related
-
2007
- 2007-06-07 TW TW096120502A patent/TW200815013A/zh unknown
- 2007-06-08 US US12/304,377 patent/US20090325984A1/en not_active Abandoned
- 2007-06-08 WO PCT/EP2007/055668 patent/WO2007144315A1/fr active Application Filing
- 2007-06-08 JP JP2009514766A patent/JP2009539921A/ja active Pending
- 2007-06-08 CA CA002654891A patent/CA2654891A1/fr not_active Abandoned
- 2007-06-08 EP EP07730023A patent/EP2026812A1/fr not_active Withdrawn
- 2007-06-12 AR ARP070102566A patent/AR061446A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2654891A1 (fr) | 2007-12-21 |
WO2007144315A1 (fr) | 2007-12-21 |
EP2026812A1 (fr) | 2009-02-25 |
AR061446A1 (es) | 2008-08-27 |
TW200815013A (en) | 2008-04-01 |
US20090325984A1 (en) | 2009-12-31 |
JP2009539921A (ja) | 2009-11-19 |
FR2902010A1 (fr) | 2007-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2902010B1 (fr) | Utilisation de la 1,7 dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene destine au traitement d'un trouble neuropsychiatrique | |
BRPI0810646A2 (pt) | " compostos farmacêuticos ". | |
FR2891460B1 (fr) | Utilisation d'au moins un compose de la famille des avermectines pour le traitement des pathologies ophtalmiques dues au demodex folliculorum. | |
FR2887139B1 (fr) | Dispositif de traitement d'un vaisseau sanguin. | |
FR2910351B1 (fr) | Catalyseur d'hydrotraitement, son procede de preparation et son utilisation. | |
FR2908999B1 (fr) | Nouveau medicament destine a l'inhibition, la prevention ou le traitement de la polyarthrite rhumatoide. | |
FR2908827B1 (fr) | Cone d'entree pour turbomachine | |
ES1058674Y (es) | Maquina licuadora perfeccionada. | |
FR2896422B1 (fr) | Systeme de drainage pour le traitement de l'hydrocephalie | |
NO20053147D0 (no) | Forsterkningsring. | |
FR2919305B1 (fr) | Vecteurs viraux adeno-associes pour l'expression de la dysferline. | |
FR2926208B1 (fr) | Ancillaire, notamment pour la pose d'une prothese de hanche. | |
FR2906468B1 (fr) | Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques | |
FR2936442B1 (fr) | Dispositif pour la fabrication d'une piece en materiau composite de forme complexe. | |
FR2904756B1 (fr) | Dispositif de maintien des seins pour application medicale. | |
FR2893321B1 (fr) | Mecanisme de pousse pour machine i.s | |
FR2884716B1 (fr) | Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires | |
FR2923064B1 (fr) | Dispositif pour stimuler la memoire d'un patient. | |
FR2926023B1 (fr) | Utilisation d'une homoproteine de la famille bicoid pour le traitement du glaucome. | |
FR2903887B1 (fr) | Seringue perfectionnee pour administration orale. | |
CL2007001456A1 (es) | Uso de compuestos derivados de 3,5-difenil 1,2,4-triazoles para el tratamiento de hemocromatosis hereditaria. | |
FR2888843B1 (fr) | Procede de preparation d'un diarylanthracene. | |
FR2882243B1 (fr) | Systeme d'amenagement pour emplacement de douche | |
FR2883180B1 (fr) | Utilisation de l'acetyl-leucine pour la preparation d'un medicament destine au traitement de troubles de l'equilibre | |
FR2918281B1 (fr) | Medicament pour le traitement de la maladie de parkinson. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20140228 |